For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||
![]() International Business Machines CorporationIBM US · Information Technology · USD Current price$223.88as of Nov 20, 2026 Summary
Analyst consensusStrong Buy 3Buy 9Hold 11Sell 1Strong Sell 123 analysts 3-year price (USD)Factor profileMulti-factor score 26 / 100 Market data
Business descriptionIBM provides full-stack technology solutions across hardware, software, and services. The company is a leader in hybrid cloud (Red Hat), enterprise AI (watsonx), and consulting services, with a dominant position in mission-critical mainframe computing (IBM Z). Competitive moatUnrivaled presence in mission-critical infrastructure; 45 of the world's top 50 banks run on IBM Z. The combination of its consulting arm with proprietary software (watsonx, Red Hat) and hardware (z17) creates an integrated ecosystem that is difficult for competitors to displace. IBM is also a first-mover and clear services leader in Quantum Computing. Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Aug 10, 2026
Current price: $223.88 · Nov 20, 2026· USD
CFRA Ratinghold
TBI Multi Score26
Theme Exposure
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: IBMBusiness description
IBM provides full-stack technology solutions across hardware, software, and services. The company is a leader in hybrid cloud (Red Hat), enterprise AI (watsonx), and consulting services, with a dominant position in mission-critical mainframe computing (IBM Z).
Competitive moat
Unrivaled presence in mission-critical infrastructure; 45 of the world's top 50 banks run on IBM Z. The combination of its consulting arm with proprietary software (watsonx, Red Hat) and hardware (z17) creates an integrated ecosystem that is difficult for competitors to displace. IBM is also a first-mover and clear services leader in Quantum Computing.
Recent developments
- Infrastructure Surge: The rollout of the z17 mainframe has triggered a massive growth cycle, with Z sales up 51% in Q1 2026. z17 offers 50% better AI inference efficiency and quantum-safe security.
- Acquisition Strategy: Bolstered hybrid cloud and data offerings with HashiCorp ($6B) and Confluent ($11B).
- Consulting Resilience: Despite fears of AI displacing human labor (COBOL modernization), IBM’s consulting signings grew 10% in Q1 2026, with GenAI now representing ~30% of total signings.
- Quantum Roadmap: Reiterated goal of delivering a large-scale, fault-tolerant quantum computer by 2029, with quantum advantage demonstrations expected in 2026.
- Efficiency Gains: Utilizing internal AI platforms (IBM Consulting Advantage) to improve consultant productivity and expand margins.
Investment risks / red flags
- Software Deceleration: Software growth slowed to 8% in Q1 2026, raising concerns about AI competition in legacy segments.
- AI Displacement: Rapid improvements in agentic AI (e.g., Claude Code) could eventually pressure the business model for COBOL and legacy code transformation.
- Leverage: Debt load remains high at $66.4B (net $54.6B) as of Q1 2026.
Market Data
Source: mkts.io · Nov 20, 2026, 10:01 UTC
Key Metrics
P/E (TTM)19.10
P/E (Fwd)16.91
Dividend3.02%
Beta0.76
52W High$332.46
52W Low$199.19
Analyst Consensus
3
9
11
Strong Buy3Buy9Hold11Sell1Strong Sell123 analysts
Consensus Target$259.85
+16.1% upside
Calendar Events
Next EarningsJan 27, 2027
Ex-DividendNov 10, 2026
Dividend DateDec 10, 2026
Financials
Revenue$69.87B
Rev Growth4.70%
Earnings Growth25.00%
Gross Margin57.97%
Op Margin18.38%
Profit Margin15.99%
EBITDA$16.63B
ROA5.33%
ROE34.77%
Rev/Share$74.31
Total Cash$11.06B
Total Debt$67.14B
D/E Ratio185.44
Free Cash Flow$12.35B
Op Cash Flow$15.83B
Current Ratio0.85
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 4.63 | $20.38B |
| +1q | 2.15 | $16.55B |
| 0y | 12.42 | $70.57B |
| +1y | 13.24 | $73.24B |
Earnings
Quarterly EPS
4Q2025
Est: 4.294.52Beat
1Q2026
Est: 1.811.91Beat
2Q2026
Est: 2.932.93Miss
3Q2026
Est: 2.872.95Beat
Annual
2022
Rev $60.53BEarn $1.64B
2023
Rev $61.86BEarn $7.50B
2024
Rev $62.75BEarn $6.02B
2025
Rev $67.53BEarn $10.59B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Oct 22, 2026 | Jefferies | main | Buy |
| Oct 22, 2026 | UBS | main | Neutral |
| Oct 22, 2026 | Citigroup | main | Buy |
| Oct 22, 2026 | Morgan Stanley | main | Equal-Weight |
| Oct 22, 2026 | BMO Capital | main | Market Perform |
| Oct 22, 2026 | Barclays | main | Overweight |
